Jingqin R Luo
Molecular Biology · 2008–2014
A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 26 citations into it
- Immunology — 18 citations into it
Whom Jingqin R Luo trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- J. Pollard (in Immunology)
Papers from Jingqin R Luo's perspective
Ordered by how strongly the researchers Jingqin R Luo trusts endorse each paper. Same corpus, a different order for every researcher.
- Alternative activation of macrophages: an immunologic functional perspective. (Annual Review of Immunology)
- Trophic macrophages in development and disease (Nature reviews. Immunology)
- Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. (Cancer Research)
- Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia (Cancer Cell)
- Tumor-derived granulocyte-macrophage colony stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer (Cancer Cell)
- CSF-1R inhibition alters macrophage polarization and blocks glioma progression (Nature Medicine)
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma (New England Journal of Medicine)
- Macrophages, innate immunity and cancer: balance, tolerance, and diversity. (Current Opinion in Immunology)
- Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression and improves chemotherapeutic responses (Cancer Research)
- Myeloid-derived-suppressor cells as regulators of the immune system (Nature reviews. Immunology)
Their papers
- Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. (2013) — 626 citations
- CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T Cell Checkpoint Immunotherapy in Pancreatic Cancer Models (2014) — 1,178 citations
- Whole Genome Analysis Informs Breast Cancer Response to Aromatase Inhibition (2012) — 1,068 citations
- Outcome Prediction for Estrogen Receptor–Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics (2008) — 617 citations